BioCentury
ARTICLE | Emerging Company Profile

AgomAb: antibodies driving tissue regeneration and recovery

Emerging Company Profile: argenx spinout AgomAb raises $74M series B to complete clinical POC for lead mAb and grow pipeline

March 11, 2021 10:33 PM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article